Diabetes Board decisions

The Board has remanded the claim of service connection for diabetes mellitus, Type II due to lack of verification of in-service herbicide exposure and need for a VA examination.

The Veteran's claim for service connection for type II diabetes mellitus was reopened due to new and material evidence. The Board denied the claims for hypertension, bilateral hearing loss, and TDIU prior to August 14, 2018.

The Board has remanded the appeal for further development and review of additional evidence, including VA and private treatment records. The issues on appeal include effective date determinations and service connection claims.

The Board has granted service connection for diabetes prior to September 3, 2021, based on the presumption of herbicide exposure in Thailand.

The Board has remanded the Veteran's claims for service connection for bilateral wrist disorders, rheumatoid arthritis, and diabetes mellitus type 2 due to inadequate medical opinions. Additional development is required.

The Board has determined that the VA opinions are inadequate to address whether the Veteran's diabetes mellitus, type II, was caused or aggravated by his service-connected left knee and left ankle disabilities with obesity as an intermediate step. Therefore, another remand is required to obtain a supplemental opinion.

The Veteran's claims for service connection have been reopened due to new and material evidence. Service connection is granted for the conditions listed, with presumptive exposure to herbicide agents.

The Board has remanded the case due to insufficient evidence regarding the etiology of the Veteran's vision loss and its relationship to his diabetes or metabolic syndrome. Additional medical opinions are needed.

The Board denied service connection for diabetes mellitus, prostate condition, erectile dysfunction, bilateral kidney condition, bilateral eye condition, and heart condition. The claims were also remanded for hypertension.

The Board has denied service connection for diabetes mellitus type 2 and remanded the issue of service connection for obstructive sleep apnea due to insufficient evidence regarding the Veteran's current diagnoses and their relationship to his service-connected conditions.

The Veteran's diabetes mellitus type II is rated at 20 percent effective July 26, 2019. The Board denied higher ratings for the condition and also denied increased ratings for erectile dysfunction and bilateral diabetic peripheral neuropathy of the lower extremities.

The Board has determined that discontinuance of the 100 percent rating for service-connected stroke associated with Type II diabetes mellitus, effective June 1, 2022, was proper.

The Board denied the Veteran's claims of service connection for Parkinson's disease, sleep apnea, diabetes mellitus, and erectile dysfunction. The evidence did not show a nexus to service.

The Veteran's appeals for increased disability ratings and reduction of disability ratings were dismissed due to the failure to timely file a Notice of Disagreement (NOD).

The Board has found that new and relevant evidence has been received to readjudicate the claim of service connection for diabetes. The Veteran's testimony during his August 2022 hearing is both new and relevant to the question of service connection for diabetes.

The motion to revise the October 2018 rating decision was granted, granting service connection for diabetes mellitus and diabetic peripheral sensory neuropathy of both lower extremities due to a history of diabetes. The appeal is mixed as some issues were granted while others were not.

The Veteran's claim for an effective date prior to August 10, 2022, for the grant of service connection for diabetes mellitus, type II, is remanded due to a duty to assist error. The Board finds that obtaining a VA examination and medical opinion regarding the etiology of the diabetes mellitus would have been necessary.

The Board has remanded the claims of service connection for COPD, prostate cancer, and diabetes mellitus type II due to insufficient evidence regarding their etiology. The Veteran's exposure to herbicides is also unclear.

The Veteran's bilateral pes planus is granted a 50% rating effective November 10, 2018. The Veteran's diabetes mellitus type II remains at a 20% rating.

The Board has remanded the case due to insufficient medical opinions regarding the relationship between the Veteran's diabetes mellitus, type II and his service-connected bilateral flat feet. The VA needs to provide a new opinion addressing whether the diabetes was caused or aggravated by the flat feet.